Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00137371
Collaborator
(none)
480
49
25
9.8
0.4
Study Details
Study Description
Brief Summary
This protocol is designed to study the effect and safety of 2 low-dose regimens of conjugated estrogen cream (PVC) given vaginally in postmenopausal women with atrophic vaginitis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Efficacy and Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women With Atrophic Vaginitis
Study Start Date
:
Aug 1, 2005
Actual Study Completion Date
:
Sep 1, 2007
Outcome Measures
Primary Outcome Measures
- To evaluate the efficacy of 2 low dose regimens of conjugated estrogen in the treatment of atrophic vaginitis from baseline to 12 weeks. []
Secondary Outcome Measures
- To evaluate change from baseline in the percentage of superficial cells, symptom relief, the effect of both regimens on endometrial stimulation and genital health. []
Eligibility Criteria
Criteria
Ages Eligible for Study:
45 Years
to 80 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
Generally healthy postmenopausal women with symptoms of atrophic vaginitis including vaginal dryness, vaginal itching, vaginal burning, and/or painful intercourse.
The subject must have a clinical diagnosis of atrophic vaginitis and an intact uterus.
Exclusion Criteria:
Women who do not have a clinical diagnosis of atrophic vaginitis.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Tucson | Arizona | United States | 85715 | |
2 | Encinitas | California | United States | 92024 | |
3 | San Diego | California | United States | 92108 | |
4 | Torrance | California | United States | 90502 | |
5 | Aurora | Colorado | United States | 80010 | |
6 | Brooksville | Florida | United States | 34613 | |
7 | Miami | Florida | United States | 33186 | |
8 | St. Petersburg | Florida | United States | 33709 | |
9 | Tampa | Florida | United States | 33066 | |
10 | West Palm Beach | Florida | United States | 33407 | |
11 | Atlanta | Georgia | United States | 30328 | |
12 | Augusta | Georgia | United States | 30901 | |
13 | Chicago | Illinois | United States | 60612 | |
14 | Metairie | Louisiana | United States | 70006 | |
15 | Troy | Michigan | United States | 48084 | |
16 | St. Louis | Missouri | United States | 63141 | |
17 | Omaha | Nebraska | United States | 68134 | |
18 | New Brunswick | New Jersey | United States | 08901 | |
19 | Chapel Hill | North Carolina | United States | 27514 | |
20 | Winston-Salem | North Carolina | United States | 27103 | |
21 | Oklahoma City | Oklahoma | United States | 73112 | |
22 | Danville | Pennsylvania | United States | 17822-2920 | |
23 | Philadelphia | Pennsylvania | United States | 19104 | |
24 | Pittsburgh | Pennsylvania | United States | 15206 | |
25 | Carrollton | Texas | United States | 75006 | |
26 | Carrollton | Texas | United States | 75010 | |
27 | Colleyville | Texas | United States | 76034 | |
28 | Dallas | Texas | United States | 75246 | |
29 | Houston | Texas | United States | 77030 | |
30 | Plano | Texas | United States | 75093 | |
31 | Charlottesville | Virginia | United States | 22903 | |
32 | Norfolk | Virginia | United States | 23502 | |
33 | Calgary | Alberta | Canada | T2N 4L7 | |
34 | Coquitlam | British Columbia | Canada | V3K 3V9 | |
35 | Langley | British Columbia | Canada | V3H 4H9 | |
36 | Winnipeg | Manitoba | Canada | R3A 1M3 | |
37 | Winnipeg | Manitoba | Canada | R3A 1R9 | |
38 | Kingston | Ontario | Canada | K7L 2V7 | |
39 | Ottawa | Ontario | Canada | K1H 7W9 | |
40 | Toronto | Ontario | Canada | M5C 1R6 | |
41 | Toronto | Ontario | Canada | M5G 1Z5 | |
42 | Toronto | Ontario | Canada | M9W 4L6 | |
43 | Montreal | Quebec | Canada | H3M 3A9 | |
44 | Montréal | Quebec | Canada | H1T 1P6 | |
45 | Montréal | Quebec | Canada | H2X 1N8 | |
46 | Pointe Claire | Quebec | Canada | H9R 4S3 | |
47 | Québec | Quebec | Canada | G1L 3L5 | |
48 | Shawinigan | Quebec | Canada | G9N 2H6 | |
49 | Sherbrooke | Quebec | Canada | J1H 5N4 |
Sponsors and Collaborators
- Wyeth is now a wholly owned subsidiary of Pfizer
Investigators
- Principal Investigator: Medical Monitor, Wyeth is now a wholly owned subsidiary of Pfizer
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00137371
Other Study ID Numbers:
- 0713S5-413
First Posted:
Aug 29, 2005
Last Update Posted:
Dec 10, 2007
Last Verified:
Dec 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: